Par Pharmaceutical

Type: Company
Name: Par Pharmaceutical
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

DEXMEDETOMIDINE HYDROCHLORIDE Injection, Solution, Concentrate [Par Pharmaceutical, Inc.]

First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

Court Finds Patent Invalid; Then Orders Defendant to Stop Infringing

By Dennis Crouch Following the Supreme Court’s equitable relief decision in eBay, many patentees have found it difficult to obtain injunctive relief to stop ongoing infringement – even after final judgment that the patent is both valid and infringed. ... [Published Patent Law Blog (Patently-O) - Aug 20 2014]
First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

FENTANYL Patch [Par Pharmaceutical Inc.]

First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

OMEGA-3-ACID ETHYL ESTERS Capsule, Liquid Filled [Par Pharmaceutical, Inc.]

First reported Aug 18 2014 - Updated Aug 18 2014 - 1 reports

OMEGA-3-ACID ETHYL ESTERS Capsule, Liquid Filled [Par Pharmaceutical, Inc.]

First reported Aug 14 2014 - Updated Aug 14 2014 - 1 reports

Injunction may delay drug launch

TWi Pharmaceuticals Inc (安成) may not be able to launch its generic version of Par Pharmaceutical Inc’s megestrol acetate — used to boost appetite and induce weight gain in patients with anorexia or AIDS — in the US market by the end of this quarter as ... [Published Taipei Times Online - Aug 14 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 2 reports

Corium Reports Third Fiscal Quarter 2014 Financial Results

MENLO PARK, Calif., Aug. 12, 2014 (GLOBE NEWSWIRE) -- . (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited results from ... [Published Industrial Info Financials - Aug 12 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 1 reports

Par Pharmaceutical Announces Quarterly Conference Call

WOODCLIFF LAKE, N.J., Aug. 6, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Wednesday, August 13, 2014 at 10:00 a.m. EDT to review its results of operations for the second quarter ended ... [Published PR Newswire: Health - Aug 06 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 1 reports

Court Report - July 2014 #3

About Court Report:  Each week we will report briefly on recently filed biotech and pharma cases .GlaxoSmithKline LLC et al. v. Glenmark Generics Inc. USA1:14-cv-00877; filed July 3, 2014 in the District Court of Delaware• Plaintiffs:  GlaxoSmithKline ... [Published JD Supra - Jul 28 2014]
First reported Jul 11 2014 - Updated Jul 11 2014 - 1 reports

FLUPHENAZINE DECANOATE Injection, Solution [Par Pharmaceutical, Inc.]

First reported Jul 09 2014 - Updated Jul 10 2014 - 2 reports

Par Pharmaceutical begins shipment of Fluphenazine Decanoate injection, USP

Par Pharmaceutical Companies has received final approval from the US Food and Drug Administration for its Abbreviated New Drug Application for fluphenazine decanoate injection, USP 25 mg/mL. ... [Published PBR - News - Jul 10 2014]
First reported Apr 23 2014 - Updated Apr 24 2014 - 2 reports

NIFEDIPINE EXTENDED-RELEASE (Nifedipine) Tablet, Extended Release [Par Pharmaceutical, Inc.]

Quotes

...to conveniently receive their dose with one spray per disposable device," said Rick Painter, Senior Vice President, Brand Sales and Marketing. "Strativa remains committed to improving the product experience of the patients who rely upon us" Mr. Painter said
...progress in advancing several product candidates for Alzheimer's and Parkinson's diseases," said Peter Staple, Chief Executive Officer of Corium. "Our R&D team has applied Corium's innovative transdermal technologies to develop lead formulations of three approved drugs with the potential to provide significantly improved treatments for patients living with these debilitating diseases. We are encouraged by the results of this work, and have initiated preclinical testing to determine the optimal formulations for human clinical trials. We anticipate that one or more of these programs will be ready to enter into Phase 1 pharmacokinetic studies in the first half of 2015."
Infringement of U S Patent Nos. 7,582,727 ( "Pharmaceutical Formulations of Bivalirudin and Process of Making the Same" issued September 1, 2009) and 7,598,343 (same title, issued October 6, 2009) following a Paragraph IV certification as part of Accord's filing of an...
The complaints in these cases are substantially identical.  Infringement of U S Patent No. RE40,000 ( "Method of Treatment for Decreasing Mortality Resulting from Congestive Heart Failure" reissued January 8, 2008) based on defendants' manufacture and sale of a generic version of GSK's Coreg® (carvedilol, used to treat congestive heart...

More Content

All (38) | News (10) | Reports (0) | Blogs (27) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
DEXMEDETOMIDINE HYDROCHLORIDE Injection, Soluti... [Published DailyMed Drug Label Updates for the last seven ... - Aug 21 2014]
Court Finds Patent Invalid; Then Orders Defenda... [Published Patent Law Blog (Patently-O) - Aug 20 2014]
FENTANYL Patch [Par Pharmaceutical Inc.] [Published DailyMed Drug Label Updates for the last seven ... - Aug 20 2014]
OMEGA-3-ACID ETHYL ESTERS Capsule, Liquid Fille... [Published DailyMed Drug Label Updates for the last seven ... - Aug 20 2014]
Strativa Pharmaceuticals Announces FDA Approval... [Published Noodls - Aug 19 2014]
OMEGA-3-ACID ETHYL ESTERS Capsule, Liquid Fille... [Published DailyMed Drug Label Updates for the last seven ... - Aug 18 2014]
Injunction may delay drug launch [Published Taipei Times Online - Aug 14 2014]
Corium Reports Third Fiscal Quarter 2014 Financ... [Published Industrial Info Financials - Aug 12 2014]
Corium Reports Third Fiscal Quarter 2014 Financ... [Published Market Pulse Navigator - Aug 12 2014]
Court Report -- Part II: August 2014 [Published JD Supra - Aug 07 2014]
Par Pharmaceutical Announces Quarterly Conferen... [Published PR Newswire: Health - Aug 06 2014]
Court Report - July 2014 #3 [Published JD Supra - Jul 28 2014]
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN Tablet... [Published DailyMed Drug Label Updates for the last seven ... - Jul 24 2014]
7/21/14 - Par Pharmaceutical Begins Shipment of... [Published Pharmacy Choice - Jul 21 2014]
FLUPHENAZINE DECANOATE Injection, Solution [Par... [Published DailyMed Drug Label Updates for the last seven ... - Jul 11 2014]
Par Pharm begins shipment of fluphenazine decan... [Published PharmaBiz - Jul 10 2014]
Par Pharmaceutical begins shipment of Fluphenaz... [Published PBR - News - Jul 10 2014]
Par Pharmaceutical Begins Shipment of Fluphenaz... [Published PR Newswire: Policy & Public Interest - Jul 09 2014]
Court Report -- Part II [Published Patent Docs - Jul 04 2014]
Stirring the Pot of AIA Alphabet Soup: Now that... [Published FDA Law Blog - Jun 24 2014]
NASCOBAL (Cyanocobalamin) Spray [Par Pharmaceut... [Published DailyMed Drug Label Updates for the last seven ... - Jun 15 2014]
NASCOBAL (Cyanocobalamin) Spray [Par Pharmaceut... [Published DailyMed Drug Label Updates for the last seven ... - Jun 12 2014]
Ignyta taps TPG Capital’s Chacko as CFO [Published PE Hub Blog - Jun 02 2014]
DANTRIUM (Dantrolene Sodium) Injection [Par Pha... [Published DailyMed Drug Label Updates for the last seven ... - May 20 2014]
Par Pharmaceutical Announces Quarterly Conferen... [Published PR Newswire: Health - May 07 2014]
NIFEDIPINE EXTENDED-RELEASE (Nifedipine) Tablet... [Published DailyMed Drug Label Updates for the last seven ... - Apr 24 2014]
NIFEDIPINE EXTENDED-RELEASE (Nifedipine) Tablet... [Published DailyMed Drug Label Updates for the last seven ... - Apr 23 2014]
FENTANYL CITRATE Lozenge [Par Pharmaceutical Inc.] [Published DailyMed Drug Label Updates for the last seven ... - Apr 20 2014]
DIGOXIN Tablet [Par Pharmaceutical, Inc] [Published DailyMed Drug Label Updates for the last seven ... - Apr 08 2014]
Par Pharmaceutical Begins Shipment of Potassium... [Published PR Newswire: Health - Apr 07 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
DEXMEDETOMIDINE HYDROCHLORIDE Injection, Soluti... [Published DailyMed Drug Label Updates for the last seven ... - Aug 21 2014]
Updated Date: Aug 21, 2014 EST ...
Court Finds Patent Invalid; Then Orders Defenda... [Published Patent Law Blog (Patently-O) - Aug 20 2014]
By Dennis Crouch Following the Supreme Court’s equitable relief decision in eBay, many patentees have found it difficult to obtain injunctive relief to stop ongoing infringement – even after final judgment that the patent is both valid and infringed. ...
FENTANYL Patch [Par Pharmaceutical Inc.] [Published DailyMed Drug Label Updates for the last seven ... - Aug 20 2014]
Updated Date: Aug 19, 2014 EST ...
OMEGA-3-ACID ETHYL ESTERS Capsule, Liquid Fille... [Published DailyMed Drug Label Updates for the last seven ... - Aug 20 2014]
Updated Date: Aug 18, 2014 EST ...
OMEGA-3-ACID ETHYL ESTERS Capsule, Liquid Fille... [Published DailyMed Drug Label Updates for the last seven ... - Aug 18 2014]
Updated Date: Aug 18, 2014 EST ...
1 2 3 4 5 6
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.